ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $9,787,118 | +11.1% | 932,995 | +39.1% | 0.00% | 0.0% |
Q3 2023 | $8,812,446 | -35.8% | 670,658 | -38.5% | 0.00% | -50.0% |
Q2 2023 | $13,729,943 | +2.2% | 1,089,678 | +5.9% | 0.00% | 0.0% |
Q1 2023 | $13,429,689 | -43.6% | 1,029,095 | -23.8% | 0.00% | -42.9% |
Q4 2022 | $23,808,126 | +14.6% | 1,349,667 | -1.0% | 0.01% | 0.0% |
Q3 2022 | $20,770,000 | +4.2% | 1,363,830 | +1.5% | 0.01% | +16.7% |
Q2 2022 | $19,931,000 | -44.4% | 1,343,972 | -15.6% | 0.01% | -33.3% |
Q1 2022 | $35,856,000 | -12.8% | 1,592,265 | -28.5% | 0.01% | -10.0% |
Q4 2021 | $41,097,000 | +157.5% | 2,227,469 | +86.6% | 0.01% | +150.0% |
Q3 2021 | $15,957,000 | -66.8% | 1,193,545 | -54.1% | 0.00% | -66.7% |
Q2 2021 | $48,098,000 | +39.1% | 2,598,448 | +12.9% | 0.01% | +33.3% |
Q1 2021 | $34,571,000 | +82.2% | 2,302,424 | +75.2% | 0.01% | +50.0% |
Q4 2020 | $18,973,000 | +79.7% | 1,314,000 | +1.3% | 0.01% | +50.0% |
Q3 2020 | $10,556,000 | +14.7% | 1,296,715 | -4.6% | 0.00% | +33.3% |
Q2 2020 | $9,207,000 | -36.4% | 1,359,938 | -33.9% | 0.00% | -50.0% |
Q1 2020 | $14,482,000 | -12.4% | 2,057,095 | +22.1% | 0.01% | +20.0% |
Q4 2019 | $16,540,000 | +284.3% | 1,685,264 | +329.9% | 0.01% | +400.0% |
Q3 2019 | $4,304,000 | -7.1% | 392,014 | -1.6% | 0.00% | 0.0% |
Q2 2019 | $4,634,000 | +46.8% | 398,474 | +20.5% | 0.00% | 0.0% |
Q1 2019 | $3,156,000 | +10.5% | 330,816 | +11.6% | 0.00% | 0.0% |
Q4 2018 | $2,856,000 | -22.6% | 296,298 | +14.5% | 0.00% | 0.0% |
Q3 2018 | $3,688,000 | -57.7% | 258,784 | -64.4% | 0.00% | -66.7% |
Q2 2018 | $8,722,000 | +35.3% | 726,802 | +39.2% | 0.00% | +50.0% |
Q1 2018 | $6,447,000 | +15.9% | 522,016 | +36.6% | 0.00% | 0.0% |
Q4 2017 | $5,561,000 | +16.0% | 382,188 | +13.5% | 0.00% | 0.0% |
Q3 2017 | $4,792,000 | +312.7% | 336,749 | +270.1% | 0.00% | – |
Q2 2017 | $1,161,000 | -24.8% | 90,987 | -25.3% | 0.00% | -100.0% |
Q1 2017 | $1,544,000 | -34.4% | 121,779 | -47.2% | 0.00% | 0.0% |
Q4 2016 | $2,354,000 | -55.7% | 230,508 | -42.9% | 0.00% | -50.0% |
Q3 2016 | $5,317,000 | -4.1% | 403,748 | -7.5% | 0.00% | 0.0% |
Q2 2016 | $5,543,000 | +24.1% | 436,419 | +29.0% | 0.00% | 0.0% |
Q1 2016 | $4,468,000 | -13.5% | 338,236 | +0.7% | 0.00% | 0.0% |
Q4 2015 | $5,167,000 | +99.9% | 335,970 | +61.2% | 0.00% | +100.0% |
Q3 2015 | $2,585,000 | +87.5% | 208,434 | +106.8% | 0.00% | 0.0% |
Q2 2015 | $1,379,000 | -94.7% | 100,794 | -95.4% | 0.00% | -90.0% |
Q1 2015 | $26,035,000 | -6.1% | 2,176,841 | +0.3% | 0.01% | -9.1% |
Q4 2014 | $27,721,000 | +2050.6% | 2,170,856 | +2158.4% | 0.01% | +1000.0% |
Q3 2014 | $1,289,000 | -13.3% | 96,122 | +3.8% | 0.00% | 0.0% |
Q2 2014 | $1,486,000 | -10.5% | 92,610 | +0.5% | 0.00% | 0.0% |
Q1 2014 | $1,661,000 | -78.7% | 92,108 | -81.7% | 0.00% | -66.7% |
Q4 2013 | $7,798,000 | -0.8% | 504,410 | -4.6% | 0.00% | 0.0% |
Q3 2013 | $7,862,000 | +84.6% | 528,729 | +60.6% | 0.00% | +50.0% |
Q2 2013 | $4,259,000 | – | 329,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |